Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.24M Buy
42,652
+1,853
+5% +$98K 0.01% 613
2026
Q1
$2.25M Sell
40,799
-1,028
-2% -$55.7K 0.01% 569
2025
Q4
$2.05M Sell
41,827
-5,546
-12% -$259K 0.01% 621
2025
Q3
$2.04M Buy
47,373
+305
+0.6% +$11.9K 0.01% 582
2025
Q2
$1.81M Buy
47,068
+4,551
+11% +$174K 0.01% 651
2025
Q1
$1.65M Sell
42,517
-6,272
-13% -$230K 0.01% 675
2024
Q4
$1.65M Sell
48,789
-5,750
-11% -$207K 0.01% 732
2024
Q3
$2.23M Sell
54,539
-625
-1% -$25.6K 0.01% 646
2024
Q2
$2.12M Buy
55,164
+119
+0.2% +$5.01K 0.01% 633
2024
Q1
$2.36M Sell
55,045
-2,824
-5% -$116K 0.01% 606
2023
Q4
$2.14M Sell
57,869
-4,308
-7% -$155K 0.01% 610
2023
Q3
$2.25M Sell
62,177
-13,411
-18% -$476K 0.01% 572
2023
Q2
$2.69M Buy
75,588
+8,777
+13% +$315K 0.01% 553
2023
Q1
$2.38M Sell
66,811
-8,877
-12% -$311K 0.01% 580
2022
Q4
$2.66M Sell
75,688
-15,493
-17% -$516K 0.01% 540
2022
Q3
$2.68M Sell
91,181
-5,971
-6% -$226K 0.01% 512
2022
Q2
$5.21M Buy
97,152
+1,563
+2% +$86.3K 0.02% 360
2022
Q1
$5.2M Buy
95,589
+649
+0.7% +$35.3K 0.02% 360
2021
Q4
$5.23M Sell
94,940
-30,668
-24% -$1.6M 0.02% 379
2021
Q3
$6M Sell
125,608
-462
-0.4% -$23.2K 0.03% 339
2021
Q2
$6.28M Sell
126,070
-1,050
-0.8% -$50.5K 0.03% 335
2021
Q1
$5.67M Sell
127,120
-9,167
-7% -$416K 0.02% 349
2020
Q4
$6.27M Sell
136,287
-18,743
-12% -$861K 0.03% 328
2020
Q3
$7.29M Sell
155,030
-3,254
-2% -$163K 0.04% 288
2020
Q2
$8.07M Sell
158,284
-11,761
-7% -$603K 0.04% 265
2020
Q1
$8.05M Sell
170,045
-12,359
-7% -$659K 0.05% 263
2019
Q4
$10.7M Sell
182,404
-1,629
-0.9% -$90.6K 0.05% 193
2019
Q3
$9.82M Sell
184,033
-2,374
-1% -$122K 0.05% 247
2019
Q2
$9.32M Sell
186,407
-638
-0.3% -$32K 0.05% 257
2019
Q1
$9.77M Sell
187,045
-2,232
-1% -$112K 0.05% 240
2018
Q4
$9.04M Sell
189,277
-12,309
-6% -$606K 0.05% 238
2018
Q3
$10.1M Buy
201,586
+5,155
+3% +$262K 0.05% 243
2018
Q2
$9.9M Buy
196,431
+3,694
+2% +$186K 0.05% 249
2018
Q1
$9.41M Sell
192,737
-7,152
-4% -$333K 0.05% 262
2017
Q4
$8.86M Sell
199,889
-470,884
-70% -$21.8M 0.05% 267
2017
Q3
$34M Buy
670,773
+468,803
+232% +$23.8M 0.18% 117
2017
Q2
$10.9M Buy
201,970
+5,355
+3% +$285K 0.06% 228
2017
Q1
$10.4M Buy
196,615
+10,880
+6% +$552K 0.06% 229
2016
Q4
$8.94M Sell
185,735
-11,643
-6% -$575K 0.06% 236
2016
Q3
$10.6M Buy
197,378
+22,807
+13% +$1.25M 0.07% 221
2016
Q2
$9.46M Buy
174,571
+14,999
+9% +$790K 0.06% 227
2016
Q1
$8.09M Sell
159,572
-874
-0.5% -$43.5K 0.05% 241
2015
Q4
$8.09M Sell
160,446
-9,482
-6% -$483K 0.05% 247
2015
Q3
$8.17M Buy
169,928
+9,732
+6% +$507K 0.06% 242
2015
Q2
$8.34M Sell
160,196
-1,991
-1% -$112K 0.05% 256
2015
Q1
$9.36M Buy
162,187
+24,759
+18% +$1.42M 0.06% 235
2014
Q4
$7.34M Sell
137,428
-4,664
-3% -$261K 0.05% 294
2014
Q3
$8.17M Buy
142,092
+110,247
+346% +$6.76M 0.05% 270
2014
Q2
$2.13M Sell
31,845
-260
-0.8% -$17.6K 0.09% 166
2014
Q1
$2.14M Sell
32,105
-603
-2% -$40.8K 0.09% 156
2013
Q4
$2.18M Sell
32,708
-611
-2% -$39.6K 0.09% 154
2013
Q3
$2.09M Buy
33,319
+1,571
+5% +$101K 0.1% 146
2013
Q2
$1.98M Buy
+31,748
New +$2.02M 0.1% 149

Other funds holding GSK

M&T Bank's GSK Position: Q2 2026 in Review

M&T Bank increased its GSK (GSK) stake by 4.5% in Q2 2026, buying an estimated $98K and bringing the position to 42,652 shares worth $2.24M. The position accounts for 0.01% of the portfolio, ranked #613.

M&T Bank first reported a position in GSK in Q2 2013 and has held it in 53 quarters since. The position peaked at $34M in Q3 2017. 1,037 funds tracked by Wall St. Rank hold GSK as of Q2 2026.

  • M&T Bank held 42,652 shares of GSK worth $2.24M as of Q2 2026.
  • M&T Bank bought 1,853 GSK shares in Q2 2026, an estimated $98K.
  • GSK made up 0.01% of M&T Bank's portfolio in Q2 2026, its #613 holding.
  • M&T Bank first reported a position in GSK in Q2 2013 and has held it in 53 quarters since.
  • M&T Bank's GSK position peaked at $34M in Q3 2017.
  • 1,037 funds tracked by Wall St. Rank held GSK as of Q2 2026.

Based on M&T Bank's 13F filing for Q2 2026, filed 4 Aug 2026.